About 200 reports

  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH
  • Clinical Trial
  • Dementia
  • Therapy
  • World
  • Biogen Idec Inc.
  • GLOBAL PREMATURE EJACULATION TREATMENT MARKET BY SSRIS 2016-2021 ($ MILLIONS)
  • SSRIS

These drugs find applications in the treatment of anxiety, depression, and personality disorders.

  • Pharmaceutical
  • Therapy
  • Forecast
  • Market Size
  • Eli Lilly & Co.
  • ASSET TRANSACTIONS
  • ACQUISITION

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Kyowa Hakko Kirin Co., Ltd.
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SANDOZ

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Biosimilar
  • Pharmaceutical
  • GlobalData's company
  • Novartis AG
  • Sandoz Inc.
  • UNIPOLAR DEPRESSION
  • Antipsychotic
  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Description

Mental illnesses can vary from anxiety and bipolar disorder to paranoia and personality disorder.

  • Mental Health
  • Pathology
  • World
  • 2.3 GLOBAL TRENDS

The size and burden of mental disorders and other disorders of the brain in Europe 2010.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Japan
  • Forecast
  • PIPELINE BY HORIZON DISCOVERY GROUP PLC, H2 2017
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Cancer
  • Hospital
  • R&D
  • Research And Development
  • AstraZeneca PLC
  • Description

disorder, Generalised anxiety disorder, Panic disorder, Post traumatic stress disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Chronic fatigue syndrome, Cognitive impairment, Delirium, Dementia, Alzheimers, Dementia with lewy

  • Mental Health
  • Pathology
  • World
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H1 2017
  • PIPELINE BY TAKEDA PHARMACEUTICAL COMPANY LTD, H1 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Digestive System Disorder
  • Hormone
  • Therapy
  • World
  • Gilead Sciences, Inc.
  • Products and services segmentation (2017)
  • KEY STATISTICS SNAPSHOT
  • Addictions
  • Mental Health
  • Pathology
  • Psychoactive Drug Consumption
  • Canada
  • GLOBAVIR BIOSCIENCES INC
  • PIPELINE BY GLOBAVIR BIOSCIENCES INC, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Chemokine
  • Lymphoma
  • Therapy
  • United States
  • Kyowa Hakko Kirin Co., Ltd.
  • Clinical Trial profile. 500 Trial Title
  • 5. All the trials included are unique trials.
  • Clinical Trial
  • Dementia
  • Hospital
  • Neurology
  • Pharmaceutical
  • Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2016
  • Kyowa Hakko Kirin Co., Ltd.

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Hormone
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Gilead Sciences, Inc.
  • KYOWA HAKKO KIRIN CO LTD
  • bleselumab

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Monoclonal Antibody
  • Therapy
  • United States
  • World
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd.

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Antimalarials
  • Infectious Disease
  • Pharmaceutical
  • Vaccine
  • World
  • ASSET PURCHASE

IT SPECIALIZES IN AGE-RELATED DISORDERS.

  • Healthcare
  • Pharmaceutical
  • Company
  • M&A
  • Aspen Pharmacare Holdings Limited
  • 7.1 GOVERNMENT
  • Global Emotional Detection and Recognition Market - By End-User - Government (Military and

personality disorder and addiction.

  • Data Analytics
  • Software
  • World
  • Affectiva, Inc.
  • Emotient, Inc.
  • ACTIVIOMICS ENTERS INTO RESEARCH AGREEMENT WITH KYOWA HAKKO
  • ACTIVIOMICS EXTENDS RESEARCH AGREEMENT WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Influenza
  • Pharmaceutical
  • United Kingdom
  • hVIVO plc
  • IO BIOTECH APS
  • PIPELINE BY IO BIOTECH APS, H1 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Cancer
  • Research And Development
  • Therapy
  • United States
  • Incyte Corporation
  • AES AT ≥5% INCIDENCE IN ADULT SCHIZOPHRENIA TRIALS OF ZYPREXA
  • OTHER SCHIZOPHRENIA SPECTRUM DISORDERS, 2015
  • Antipsychotic
  • Hospital
  • Mental Health
  • Psychotic Disorder
  • Therapy
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Disorder, Schizophrenia Ongoing, recruiting Phase II Interventional PF-## Yale University National Center for Advancing Translational Sciences ## Aug 2013 ## Jul 2018 ## ## ## Sodium And Chloride Dependent Glycine Transporter ## (Glyt## or Solute Carrier Family ## Member ## or SLC##A##) Inhib

  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • Psychotic Disorder
  • World
  • KYOWA HAKKO KIRIN CO LTD
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017

It specializes in age-related disorders.

  • Dementia
  • Pain Relief
  • Pharmaceutical
  • Therapy
  • Flex Pharma, Inc.
  • Clinical Trial profile. 6 Trial Title
  • Prominent Drugs
  • Depression
  • Hormone
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 197 Trial Title
  • Prominent Drugs
  • Addictions
  • Neurology
  • Opioid
  • Therapy
  • Alkermes plc
  • SANFORD HEALTH ACQUIRES HEMATECH, DRUG DEVELOPMENT COMPANY

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Health Services
  • Healthcare
  • Pharmaceutical
  • United States
  • GlobalData's company
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • KYOWA HAKKO KIRIN CO LTD

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • MedImmune, LLC
  • International Society for the Study of Fatty Acids and Lipids (ISSFAL)
  • 5. GLOBAL NUTRITIONAL LIPIDS MARKET, BY TYPE

It is also used for high blood pressure in high-risk pregnancies (eclampsia), Age-related Macular Degeneration (AMD), schizophrenia, personality disorder, cystic fibrosis, Alzheimer' s disease, depression, and diabetes.

  • OTC
  • Europe
  • North America
  • World
  • Market Size
  • KYOWA HAKKO KIRIN CO., LTD.
  • PIPELINE BY KYOWA HAKKO KIRIN CO., LTD., H1 2016

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Chemokine
  • Hospital
  • Therapy
  • Product Initiative
  • Kyowa Hakko Kirin Co., Ltd.
  • FUJIFILM FORMS JOINT VENTURE WITH KYOWA HAKKO KIRIN

Parent Fujifilm Holdings Corporation epilepsy, behavioral or personality disorders and others.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • FUJIFILM Holdings Corporation